L-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats

Jiwoong Jang, Jonghoon Park, Hyukki Chang, Kiwon Lim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

L-Carnitine was recently found to downregulate the ubiquitin proteasome pathway (UPP) and increase insulin-like growth factor 1 concentrations in animal models. However, the effect of L-carnitine administration on disuse muscle atrophy induced by hindlimb suspension has not yet been studied. Thus, we hypothesized that L-carnitine may have a protective effect on muscle atrophy induced by hindlimb suspension via the Akt1/mTOR and/or UPP. Male Wistar rats were assigned to 3 groups: hindlimb suspension group, hindlimb suspension with L-carnitine administration (1250 mg.kg-1.day-1) group, and pair-fed group adjusted hindlimb suspension. L-Carnitine administration for 2 weeks of hindlimb suspension alleviated the decrease in weight and fiber size in the soleus muscle. In addition, L-carnitine suppressed atrogin-1 mRNA expression, which has been reported to play a pivotal role in muscle atrophy. The present study shows that L-carnitine has a protective effect against soleus muscle atrophy caused by hindlimb suspension and decreased E3 ligase messenger RNA expression, suggesting the possibility that L-carnitine protects against muscle atrophy, at least in part, through the inhibition of the UPP. These observations suggest that L-carnitine could serve as an effective supplement in the decrease of muscle atrophy caused by weightlessness in the fields of clinical and rehabilitative research.

Original languageEnglish
Pages (from-to)1240-1247
Number of pages8
JournalApplied Physiology, Nutrition and Metabolism
Volume41
Issue number12
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Hindlimb Suspension
Muscular Atrophy
Carnitine
Skeletal Muscle
Proteasome Endopeptidase Complex
Ubiquitin
Atrophic Muscular Disorders
Weightlessness
Messenger RNA
Ubiquitin-Protein Ligases
Somatomedins
Wistar Rats
Down-Regulation
Animal Models
Weights and Measures

Keywords

  • Catabolic condition
  • Hindlimb suspension
  • L-carnitine
  • Muscle atrophy
  • Muscle-specific ubiquitin E3 ligases
  • Weightless

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Nutrition and Dietetics
  • Physiology (medical)

Cite this

L-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats. / Jang, Jiwoong; Park, Jonghoon; Chang, Hyukki; Lim, Kiwon.

In: Applied Physiology, Nutrition and Metabolism, Vol. 41, No. 12, 01.01.2016, p. 1240-1247.

Research output: Contribution to journalArticle

@article{971fb646bfbc478bb32d1f172c3061d0,
title = "L-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats",
abstract = "L-Carnitine was recently found to downregulate the ubiquitin proteasome pathway (UPP) and increase insulin-like growth factor 1 concentrations in animal models. However, the effect of L-carnitine administration on disuse muscle atrophy induced by hindlimb suspension has not yet been studied. Thus, we hypothesized that L-carnitine may have a protective effect on muscle atrophy induced by hindlimb suspension via the Akt1/mTOR and/or UPP. Male Wistar rats were assigned to 3 groups: hindlimb suspension group, hindlimb suspension with L-carnitine administration (1250 mg.kg-1.day-1) group, and pair-fed group adjusted hindlimb suspension. L-Carnitine administration for 2 weeks of hindlimb suspension alleviated the decrease in weight and fiber size in the soleus muscle. In addition, L-carnitine suppressed atrogin-1 mRNA expression, which has been reported to play a pivotal role in muscle atrophy. The present study shows that L-carnitine has a protective effect against soleus muscle atrophy caused by hindlimb suspension and decreased E3 ligase messenger RNA expression, suggesting the possibility that L-carnitine protects against muscle atrophy, at least in part, through the inhibition of the UPP. These observations suggest that L-carnitine could serve as an effective supplement in the decrease of muscle atrophy caused by weightlessness in the fields of clinical and rehabilitative research.",
keywords = "Catabolic condition, Hindlimb suspension, L-carnitine, Muscle atrophy, Muscle-specific ubiquitin E3 ligases, Weightless",
author = "Jiwoong Jang and Jonghoon Park and Hyukki Chang and Kiwon Lim",
year = "2016",
month = "1",
day = "1",
doi = "10.1139/apnm-2016-0094",
language = "English",
volume = "41",
pages = "1240--1247",
journal = "Applied Physiology, Nutrition and Metabolism",
issn = "1715-5312",
publisher = "National Research Council of Canada",
number = "12",

}

TY - JOUR

T1 - L-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats

AU - Jang, Jiwoong

AU - Park, Jonghoon

AU - Chang, Hyukki

AU - Lim, Kiwon

PY - 2016/1/1

Y1 - 2016/1/1

N2 - L-Carnitine was recently found to downregulate the ubiquitin proteasome pathway (UPP) and increase insulin-like growth factor 1 concentrations in animal models. However, the effect of L-carnitine administration on disuse muscle atrophy induced by hindlimb suspension has not yet been studied. Thus, we hypothesized that L-carnitine may have a protective effect on muscle atrophy induced by hindlimb suspension via the Akt1/mTOR and/or UPP. Male Wistar rats were assigned to 3 groups: hindlimb suspension group, hindlimb suspension with L-carnitine administration (1250 mg.kg-1.day-1) group, and pair-fed group adjusted hindlimb suspension. L-Carnitine administration for 2 weeks of hindlimb suspension alleviated the decrease in weight and fiber size in the soleus muscle. In addition, L-carnitine suppressed atrogin-1 mRNA expression, which has been reported to play a pivotal role in muscle atrophy. The present study shows that L-carnitine has a protective effect against soleus muscle atrophy caused by hindlimb suspension and decreased E3 ligase messenger RNA expression, suggesting the possibility that L-carnitine protects against muscle atrophy, at least in part, through the inhibition of the UPP. These observations suggest that L-carnitine could serve as an effective supplement in the decrease of muscle atrophy caused by weightlessness in the fields of clinical and rehabilitative research.

AB - L-Carnitine was recently found to downregulate the ubiquitin proteasome pathway (UPP) and increase insulin-like growth factor 1 concentrations in animal models. However, the effect of L-carnitine administration on disuse muscle atrophy induced by hindlimb suspension has not yet been studied. Thus, we hypothesized that L-carnitine may have a protective effect on muscle atrophy induced by hindlimb suspension via the Akt1/mTOR and/or UPP. Male Wistar rats were assigned to 3 groups: hindlimb suspension group, hindlimb suspension with L-carnitine administration (1250 mg.kg-1.day-1) group, and pair-fed group adjusted hindlimb suspension. L-Carnitine administration for 2 weeks of hindlimb suspension alleviated the decrease in weight and fiber size in the soleus muscle. In addition, L-carnitine suppressed atrogin-1 mRNA expression, which has been reported to play a pivotal role in muscle atrophy. The present study shows that L-carnitine has a protective effect against soleus muscle atrophy caused by hindlimb suspension and decreased E3 ligase messenger RNA expression, suggesting the possibility that L-carnitine protects against muscle atrophy, at least in part, through the inhibition of the UPP. These observations suggest that L-carnitine could serve as an effective supplement in the decrease of muscle atrophy caused by weightlessness in the fields of clinical and rehabilitative research.

KW - Catabolic condition

KW - Hindlimb suspension

KW - L-carnitine

KW - Muscle atrophy

KW - Muscle-specific ubiquitin E3 ligases

KW - Weightless

UR - http://www.scopus.com/inward/record.url?scp=84996538637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996538637&partnerID=8YFLogxK

U2 - 10.1139/apnm-2016-0094

DO - 10.1139/apnm-2016-0094

M3 - Article

C2 - 27841025

AN - SCOPUS:84996538637

VL - 41

SP - 1240

EP - 1247

JO - Applied Physiology, Nutrition and Metabolism

JF - Applied Physiology, Nutrition and Metabolism

SN - 1715-5312

IS - 12

ER -